These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35288387)

  • 1. Multicentre randomised controlled trial: protocol for Plasma-Lyte Usage and Assessment of Kidney Transplant Outcomes in Children (PLUTO).
    Hayes W; Laing E; Foley C; Pankhurst L; Thomas H; Hume-Smith H; Marks S; Kessaris N; Bryant WA; Spiridou A; Wray J; Peters MJ
    BMJ Open; 2022 Mar; 12(3):e055595. PubMed ID: 35288387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO).
    Hayes WN; Laing E; Brown R; Silsby L; Smith L; Thomas H; Kaloyirou F; Sharma R; Griffiths J; Hume-Smith H; Marks SD; Kessaris N; Christian M; Dudley J; Shenoy M; Malina M; Muorah M; Ware N; Yadav P; Reynolds B; Bryant W; Spiridou A; Wray J; Peters MJ
    Kidney Int; 2024 Feb; 105(2):364-375. PubMed ID: 37914088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
    Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ;
    Trials; 2020 May; 21(1):428. PubMed ID: 32450917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU-a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial.
    Raman S; Schibler A; Marsney RL; Trnka P; Kennedy M; Mattke A; Gibbons K; Schlapbach LJ
    Trials; 2021 Jul; 22(1):427. PubMed ID: 34217337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical analysis plan for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantation.
    Pascoe EM; Chadban SJ; Fahim MA; Hawley CM; Johnson DW; Collins MG;
    Trials; 2022 Jan; 23(1):52. PubMed ID: 35042554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial.
    Williams V; Jayashree M; Nallasamy K; Dayal D; Rawat A
    Crit Care; 2020 Jan; 24(1):1. PubMed ID: 31898531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma electrolyte imbalance in pediatric kidney transplant recipients.
    Hayes W; Longley C; Scanlon N; Bryant W; Stojanovic J; Kessaris N; Van't Hoff W; Bockenhauer D; Marks SD
    Pediatr Transplant; 2019 Jun; 23(4):e13411. PubMed ID: 30973673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of 0.9% saline versus Plasma-Lyte 148 on renal function as assessed by creatinine concentration in patients undergoing major surgery: A single-centre double-blinded cluster crossover trial.
    Weinberg L; Li MH; Churilov L; Macgregor C; Garrett K; Eyles J; Bellomo R
    PLoS One; 2021; 16(5):e0251718. PubMed ID: 34010324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial.
    Collins MG; Fahim MA; Pascoe EM; Hawley CM; Johnson DW; Varghese J; Hickey LE; Clayton PA; Dansie KB; McConnochie RC; Vergara LA; Kiriwandeniya C; Reidlinger D; Mount PF; Weinberg L; McArthur CJ; Coates PT; Endre ZH; Goodman D; Howard K; Howell M; Jamboti JS; Kanellis J; Laurence JM; Lim WH; McTaggart SJ; O'Connell PJ; Pilmore HL; Wong G; Chadban SJ; ;
    Lancet; 2023 Jul; 402(10396):105-117. PubMed ID: 37343576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing fluids to reduce the risks of acute electrolyte disturbances in children after a kidney transplant.
    Venkataraman K; McTaggart SJ; Collins MG
    Kidney Int; 2024 Feb; 105(2):247-250. PubMed ID: 38245215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Plasma-Lyte.½ and 0.9% saline in renal function after deceased-donor kidney transplant: a randomized controlled trial.
    do Nascimento Junior P; Dohler LE; Ogawa CMU; de Andrade LÍGM; Braz LG; M Dolo NSP
    Braz J Anesthesiol; 2022; 72(6):711-719. PubMed ID: 34563559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre randomised controlled pilot study of fluid resuscitation with saline or Plasma-Lyte 148 in critically ill patients.
    Verma B; Luethi N; Cioccari L; Lloyd-Donald P; Crisman M; Eastwood G; Orford N; French C; Bellomo R; Martensson J
    Crit Care Resusc; 2016 Sep; 18(3):205-12. PubMed ID: 27604335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal saline versus lower-chloride solutions for kidney transplantation.
    Wan S; Roberts MA; Mount P
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010741. PubMed ID: 27502170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intraoperative and early postoperative normal saline or Plasma-Lyte 148® on hyperkalaemia in deceased donor renal transplantation: a double-blind randomized trial.
    Weinberg L; Harris L; Bellomo R; Ierino FL; Story D; Eastwood G; Collins M; Churilov L; Mount PF
    Br J Anaesth; 2017 Oct; 119(4):606-615. PubMed ID: 29121282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physico-chemical stability of Plasma-Lyte 148® and Plasma-Lyte 148® + 5% Glucose with eight common intravenous medications.
    Dawson R; Wignell A; Cooling P; Barrett D; Vyas H; Davies P
    Paediatr Anaesth; 2019 Feb; 29(2):186-192. PubMed ID: 30472805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Plasma-Lyte 148 v Saline (PLUS) study protocol: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality.
    Hammond NE; Bellomo R; Gallagher M; Gattas D; Glass P; Mackle D; Micallef S; Myburgh J; Saxena M; Taylor C; Young P; Finfer S
    Crit Care Resusc; 2017 Sep; 19(3):239-246. PubMed ID: 28866974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: a comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution.
    Davies PG; Venkatesh B; Morgan TJ; Presneill JJ; Kruger PS; Thomas BJ; Roberts MS; Mundy J
    Crit Care; 2011; 15(1):R21. PubMed ID: 21235742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium reduction during cardiopulmonary bypass: Plasma-Lyte 148 versus trial fluid as pump primes.
    Morgan TJ; Presneill JJ; Davies PG; Power G; Venkatesh B
    Crit Care Resusc; 2015 Dec; 17(4):263-7. PubMed ID: 26640062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study.
    Reddy SK; Bailey MJ; Beasley RW; Bellomo R; Henderson SJ; Mackle DM; McArthur CJ; Mehrtens JE; Myburgh JA; McGuinness SP; Psirides AJ; Young PJ
    Crit Care Resusc; 2014 Dec; 16(4):274-9. PubMed ID: 25437221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid-base effects of a bicarbonate-balanced priming fluid during cardiopulmonary bypass: comparison with Plasma-Lyte 148. A randomised single-blinded study.
    Morgan TJ; Power G; Venkatesh B; Jones MA
    Anaesth Intensive Care; 2008 Nov; 36(6):822-9. PubMed ID: 19115651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.